DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. Research Programs
  3. Military Burn
  4. Research Highlights/News
  5. 2021 Military Burn Research Program

Military Burn

NEWS RELEASE

Released: January 15, 2021

Department of Defense Military Burn Research Program
Anticipated Funding Opportunities for Fiscal Year 2021 (FY21)

Although the Fiscal Year 2021 (FY21) Defense Appropriations Bill has been signed into law, the FY21 appropriation for the Department of Defense Military Burn Research Program (MBRP) is contingent upon the outcome of a pending rescissions request. The MBRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY21 funding opportunities. This pre-announcement should not be construed as an obligation by the Government.

The FY21 Defense Appropriations Act is anticipated to provide funding to the Department of Defense MBRP to support a research portfolio in the treatment of burns and the trauma associated with burn injuries sustained during combat or combat-related activities. Outcomes of successful research are anticipated to benefit Service members, Veterans, and the general public. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC). 

Subject to the FY21 Congressional appropriation for MBRP funding, FY21 MBRP Program Announcements and General Application Instructions for the following award mechanisms will be posted on the Grants.gov website. Pre-application and application deadlines will be available when the Program Announcements are released. 

The MBRP encourages applications proposing research that advances the development or refinement of interventions, technologies, or knowledge projects that will facilitate appropriate burn care closer to the point of injury to enhance the potential for better long-term outcomes. Applications submitted to the FY21 MBRP must address the following Focus Area: 

Complex combat-related burns: Development and/or validation of therapeutic interventions to treat military-relevant burn injury (heat, cold, chemical, or electrical) combined with other injuries including, but not limited to, hemorrhage, radiation, and/or polytrauma. Interventions or projects scalable to mass casualty events are of particular interest to the MBRP.


Award Mechanism Eligibility Key Mechanism Elements Funding
Clinical Translational Research Award Independent investigators at all academic levels (or equivalent) may be named as PI in the application.
  • Supports clinical research projects that are likely to have a major impact on therapy by applying promising and well-founded laboratory, preclinical, or clinical research findings to the care of the burn-injured patient.
  • The proposed study must include clinical research, and may include initial proof-of-concept trials, studies involving use of human anatomical substances, observational studies, and/or involve some retrospective data analysis.
  • Large randomized clinical trials are discouraged.
  • Preliminary data is required.
  • Animal research is not allowed.
  • Pre-application is required; application submission is by invitation only.
  • Maximum funding of $1.5 million (M) for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 4 years.
Idea Development Award Independent investigators at all academic levels (or equivalent) may be named as PI in the application.
  • Supports innovative research in the field of burn wound care.
  • Inclusion of preliminary and/or published data relevant to the proposed research is required.
  • Feasibility and Impact are important review criteria.
  • Clinical trials are not allowed.
  • Pre-application is required; application submission is by invitation only.
  • Maximum funding of $600,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 3 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the MBRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.health.mil).

Point of Contact:

CDMRP Public Affairs
301-619-9783
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil